Alvotech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Robert Wessman
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 98.3% |
| CEO tenure | 2yrs |
| CEO ownership | n/a |
| Management average tenure | 2yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Alvotech's Position In The Coming Biosimilar Gold Rush
Nov 21Alvotech: Steady Progress Offers A Good Chance Of Upside
Aug 26Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts
May 28
Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
Apr 25Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically
Sep 03Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump
May 05Shareholders Shouldn’t Be Too Comfortable With Alvotech's (NASDAQ:ALVO) Strong Earnings
Nov 23Fuji Pharma files for approval of biosimilar candidate in Japan
Oct 17Alvotech and STADA launch Humira biosimilar in Switzerland
Sep 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$441m |
| Jun 30 2024 | n/a | n/a | -US$618m |
| Mar 31 2024 | n/a | n/a | -US$494m |
| Dec 31 2023 | US$2m | US$1m | -US$552m |
| Sep 30 2023 | n/a | n/a | -US$596m |
| Jun 30 2023 | n/a | n/a | -US$416m |
| Mar 31 2023 | n/a | n/a | -US$713m |
| Dec 31 2022 | US$740k | n/a | -US$514m |
Compensation vs Market: Robert's total compensation ($USD1.52M) is below average for companies of similar size in the US market ($USD6.66M).
Compensation vs Earnings: Robert's compensation has increased whilst the company is unprofitable.
CEO
Robert Wessman (54 yo)
2yrs
Tenure
US$1,517,000
Compensation
Mr. Robert Wessman serves as Chief Executive Officer of Alvotech since January 1, 2023. He Founded Alvotech in 2013 and serves as its Executive Chairman and Member of the Board of Directors since January 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Founder & Executive Chairman | 2yrs | US$1.52m | no data | |
| COO & Director | 1.3yrs | no data | 0% $ 0 | |
| Chief Financial Officer | 4.9yrs | no data | 0.032% $ 1.3m | |
| Chief Technical Officer | no data | no data | no data | |
| Chief Scientific Officer | 5.3yrs | no data | 0.051% $ 2.0m | |
| VP of Investor Relations and Global Communications | no data | no data | no data | |
| General Counsel | 2yrs | no data | 0% $ 0 | |
| Vice President of People & Culture | less than a year | no data | no data | |
| Chief Commercial Officer | 6.5yrs | no data | no data | |
| Chief Strategy Officer | 5yrs | no data | no data | |
| Chief Quality Officer | less than a year | no data | no data | |
| Chief Regulatory Affairs Officer | less than a year | no data | no data |
2.0yrs
Average Tenure
48yo
Average Age
Experienced Management: ALVO's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Founder & Executive Chairman | 6yrs | US$1.52m | no data | |
| COO & Director | 4.6yrs | no data | 0% $ 0 | |
| Director | no data | no data | no data | |
| Independent Non-Executive Director | 2.6yrs | US$81.00k | 0.0035% $ 140.1k | |
| Non-Executive Director | 2.6yrs | US$71.00k | 0.0035% $ 140.1k | |
| Non-Executive Director | 6yrs | no data | no data | |
| Non-Executive Director | 2.6yrs | no data | no data | |
| Independent Non-Executive Deputy Chairman | 6yrs | US$156.00k | 0.35% $ 14.0m | |
| Independent Non-Executive Director | 2.6yrs | US$113.00k | 0.0035% $ 140.1k |
3.6yrs
Average Tenure
57yo
Average Age
Experienced Board: ALVO's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 04:08 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alvotech is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Balaji Prasad | Barclays |
| Balaji Prasad | Barclays |
| Peter Verdult | Citigroup Inc |